Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Eli Lilly to Acquire Drug Developer Ventyx for $1.2 Billion, Expanding in Autoimmune Field

Eli Lilly to Acquire Drug Developer Ventyx for $1.2 Billion, Expanding in Autoimmune Field

格隆汇格隆汇2026/01/08 02:13
Show original
By:格隆汇
Gelonghui Jan 8th|Eli Lilly will acquire autoimmune drug developer Ventyx Biosciences at a price of $14 per share, with the deal valued at $1.2 billion. Ventyx is developing multiple therapeutic drugs, including oral therapies for inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, as well as medications for immune-related diseases, cardiometabolic diseases, and neurodegenerative diseases. In addition, the company is conducting a mid-stage trial for a drug targeting obesity-related cardiovascular diseases, which could potentially complement Eli Lilly's metabolic and immunology franchises. The transaction is expected to be completed in the first half of this year.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Samsung Electronics Q3 Revenue and Operating Profit Hit Record Highs, but Net Profit Still Below Expectations

Samsung Electronics reported a net profit of 75.21 trillion KRW for the third quarter, compared to an estimated 89.06 trillion KRW. The operating profit for the third quarter was 107.44 trillion KRW. Third-quarter sales reached 195.25 trillion KRW. Chip sales for the third quarter amounted to 147.1 trillion KRW. Samsung plans to announce its shareholder return plan at the end of January, with plans to distribute a 30 trillion KRW cash dividend for the third quarter.

华尔街见闻•2026/10/29 01:36

$17 Billion Acquisition Countdown: DoorDash (DASH.US) Plans to Acquire Instacart to Enter the Home Shopping Battlefield, Official Announcement as Early as Thursday

DoorDash's core intention in acquiring Instacart is to extend the user access and delivery network established through food delivery to the larger-scale household supermarket shopping scenario. The deal originated from Instacart exploring a sale and contacting potential buyers such as Uber and DoorDash. By October 26, multiple media outlets reported both parties had entered deep negotiations, with the potential transaction valued at approximately $17 billion.

智通财经•2026/10/29 01:27

Federal Reserve Holds Rates Steady, Oracle (ORCL.US) Surges 11% to Ignite Tech Stock Rally

The Federal Reserve maintained its interest rates at 3.75%~4.00%. Combined with Oracle’s strong growth guidance and SK Hynix’s record profits, the S&P 500 index rose for the third consecutive day, and the Nasdaq closed up 0.27%. Market focus is shifting to earnings reports from major tech companies.

智通财经•2026/10/29 01:12

99.3% shareholder vote: MicroStrategy (MSTR.US) preferred stock to start daily dividends

MicroStrategy has passed the bylaws amendment with a 99.3% approval rate, establishing a daily cumulative dividend mechanism for four preferred stocks including STRF. This move, together with a $204.9 million buyback plan, aims to address the risk of removal from the MSCI index and stabilize stock price volatility.

智通财经•2026/10/29 01:11
99.3% shareholder vote: MicroStrategy (MSTR.US) preferred stock to start daily dividends